Literature DB >> 25854407

Survival rates of cervical cancer patients in Malaysia.

Nor Asiah Muhamad1, Muhammad Amir Kamaluddin, Mohd Yusoff Adon, Mohamed Asyraf Noh, Mohammed Faizal Bakhtiar, Nor Saleha Ibrahim Tamim, Siti Haniza Mahmud, Tahir Aris.   

Abstract

Cervical cancer is the most common malignant cancer of the female reproductive organs worldwide. Currently, cervical cancer can be prevented by vaccination and detected at an early stage via various screening methods. Malaysia, as a developing country faces a heavy disease burden of cervical cancer as it is the second most common cancer among Malaysian women. This population based study was carried out to fulfil the primary aim of determining the survival rates of Malaysian women with cervical cancer and associated factors. Data were obtained from two different sources namely, the Malaysian National Cancer Registry (MNCR) and National Health Informatics Centre (NHIC) from 1st January 2000 to 31st December 2005. Kaplan Meier analyses were conducted to identify the overall survival rates and median survival time. Differences in survival among different ethnic and age group were compared using the log-rank test. A total of 5,859 patients were included. The median survival time for cervical cancer in this study was 65.8 months and the 5-year survival rate was 71.1%. The overall observed survival rates at 1, 3 and 5 years were 94.1%, 79.3% and 71.1% respectively. The log-rank test finding also showed that there were significant differences in the 5-year survival rate among different ethnic groups. Malays had the lowest survival rate of 59.2% followed by Indians (69.5%) and Chinese (73.8%). The overall 5-year survival rate among patients with cervical cancer in Malaysia is relatively good. Age and ethnic groups remain as significant determining factors for cervical cancer survival rate.

Entities:  

Mesh:

Year:  2015        PMID: 25854407     DOI: 10.7314/apjcp.2015.16.7.3067

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.

Authors:  Nisreen Anfinan; Khalid Sait
Journal:  Ann Saudi Med       Date:  2020-02-06       Impact factor: 1.526

2.  Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.

Authors:  Mulugeta Wassie; Zeleke Argaw; Yosief Tsige; Mesfin Abebe; Sezer Kisa
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

3.  The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.

Authors:  Adam Keane; Chiu Wan Ng; Kate T Simms; Diep Nguyen; Yin Ling Woo; Marion Saville; Karen Canfell
Journal:  Int J Cancer       Date:  2021-08-25       Impact factor: 7.316

4.  Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.

Authors:  Mohadeseh Hasanpourghadi; Chandrabose Karthikeyan; Ashok Kumar Pandurangan; Chung Yeng Looi; Piyush Trivedi; Kinue Kobayashi; Kozo Tanaka; Won Fen Wong; Mohd Rais Mustafa
Journal:  J Exp Clin Cancer Res       Date:  2016-03-31

5.  Survival Analysis of Cervical Cancer Patients: A Case Study of Bhutan.

Authors:  Ugyen Tshewang; Pairote Satiracoo; Yongwimon Lenbury
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01

6.  Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study.

Authors:  Mohd Nasrullah Nik Ab Kadir; Suhaily Mohd Hairon; Najib Majdi Yaacob; Azizah Ab Manan; Nabihah Ali
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.